Organ-on-a-chip (OOC) technology offers you a transformative approach to better science. By bridging the gaps between traditional cell culture, animal models and the clinic, its complementary use offers the promise of deeper, human-relevant insights and more informed decisions about the right therapeutics to take forward into trials. The potential of OOC to reduce drug attrition rates, bring novel therapeutics to patients more rapidly and cost-effectively has piqued the interest of early adopters, eager to recreate intricate human physiology in the laboratory. For others, the jury remains out and questions remain. Do transitional challenges outweigh the potential benefits, is the technology ready for primetime? While there are hurdles associated with adopting any disruptive technology, by considering these upfront it is possible for you to make the complex simple, to ease the transition into OOC and to reap the benefits faster. In this article, we address some common concerns and present a realistic perspective on the adoption challenges that surround OOC. Read More